Home/Pipeline/LBS-003

LBS-003

Dry Age‑Related Macular Degeneration

PreclinicalActive

Key Facts

Indication

Dry Age‑Related Macular Degeneration

Phase

Preclinical

Status

Active

Company

Lin BioScience

About Lin BioScience

Taiwan‑based biotech developing oral small‑molecule drugs for eye disease, cancer and metabolic disorders, with multiple FDA‑designated clinical programs.

View full company profile

Therapeutic Areas

Ophthalmology Oncology Metabolic Disease

Other Dry Age‑Related Macular Degeneration Drugs

Drug	Company	Phase	Status
Induced Retinal Pigment Epithelium (RPE) Cells	Esco Aster	Phase 1/2	Active